Glomangiosarcoma, or malignant glomus tumor, is a very rare neoplasm that when seen typically arises from a benign glomus tumor. Despite having histologic features of malignancy, these tumors usually do not metastasize. However, when metastasis occurs this disease is often fatal. We report a case of a malignant glomus tumor arising de novo on the nose of an 89-yearold white woman, and we review the literature concerning glomangiosarcomas.
GLOMANGIOSARCOMA, ALSO KNOWN as malignant glomus tumor, is an exceedingly rare cutaneous neoplasm. Most glomangiosarcomas do not metastasize despite exhibiting histologic features of malignancy. 1 As such, there has been controversy regarding the true malignant nature of this tumor over the last few decades. 2 While the existence of solitary and multiple benign glomus tumors is a well-recognized phenomenon in dermatology, the development of its malignant counterpart (glomangiosarcoma) in the skin is a rare occurrence. When seen, glomangiosarcomas typically arise as painful dermal nodules with a predilection for the lower extremities. 3, 4 We report a case of malignant glomus tumor and review the clinical and histologic features of this neoplasm.
Case Report
An 89-year-old white woman presented with a several-month history of a slowly enlarging, erythematous, vascular, ill-defined tumor involving the nasal bridge. The lesion initially arose as a small erythematous papule that occasionally demonstrated spontaneous erosion and reepithelialization. The tumor remained essentially asymptomatic until just before presentation, when occasional pain and tenderness developed. There was no history of trauma. Physical examination revealed no lymphadenopathy. Full physical examina-tion by the patient's internist revealed no internal abnormalities. In addition, a CBC with differential, as well as a comprehensive metabolic panel was normal. Chest X-ray revealed only mild cardiomegaly. The remainder of the cutaneous examination was unremarkable.
Histopathologic examination revealed features of a glomangiosarcoma arising de novo. The exophytic nodule existed predominately in the reticular dermis extending superficially, ulcerating the overlying epidermis ( Figure 1 ). The tumor consisted of sheets of neoplastic cells containing small round vesicular nuclei, inconspicuous nucleoli, and varying amounts of cytoplasm. The cells exhibited a high mitotic rate of 30 mitoses/10 hpf ( Figure 2 ). Numerous small capillary-size vessels were found within the neoplasm. Immunohistochemical stains revealed diffuse MIB-1 staining throughout the tumor. Cells stained positively for vimentin ( Figure 3 ), smooth muscle actin ( Figure 4 ), and to a lesser extent pan-muscle actin.
Because of the ill-defined nature of the tumor and concerns for tissue conservation, definitive excision was performed with Mohs micrographic surgery. Examination of the frozen sections was performed with hematoxylin and eosin staining. Special stains were not used during the Mohs procedure, as the histology was easily distinguished from the surrounding uninvolved tissue. The patient was clinically free of disease at her most recent follow-up 4 years after treatment.
Discussion
Glomus tumors arise from the glomus body, a distinct arteriovenous anastomosis in the reticular dermis involved in thermoregulation. 5 Like its benign counterpart, malignant glomus tumor typically presents as pain-ful blue-red dermal nodules ranging from 0.5 to 2.0 cm in diameter. These malignant neoplasms have a predilection for the lower extremities, although they have been described on the face and elsewhere. [6] [7] [8] [9] [10] [11] In 1924 Masson was the first to describe the histologic features of the glomus tumor. 5 The solitary glomus tumor is a well-circumscribed lesion consisting of tightly coiled capillary-size vessels and glomus cells arranged in a perivascular pattern. Glomus cells are characterized by a round to cuboidal, pale, punched-out nucleus and faintly staining eosinophilic cytoplasm. Glomangiosarcomas, which often appear to arise from a preexisting glomus tumor, typically consist of mitotically active pleomorphic cells. 12 Such mitotic activity is not a feature of glomus tumors ( Figure 2 ).
In an attempt to refine the histologic spectrum of malignant glomus tumors, Gould et al. 12 classified le-sions into three groups; locally infiltrative glomus tumors (LIGT), which are histologically identical to the benign solitary glomus tumors, except for their infiltrative growth pattern; glomangiosarcoma arising from a benign glomus tumor (GABG), which are sarcomatous tumors arising from preexisting glomus tumors; and glomangiosarcoma arising de novo (GADN), which are tumors exhibiting a high mitotic rate, but lack histologic evidence of benign glomus origin. Based on this scheme, the majority of reported glomangiosarcomas are of the GABG variety. Our case, however, appears to arise de novo.
Immunohistologically, malignant glomus cells retain many antigens expressed by their benign counterparts, staining positive for vimentin, smooth muscle actin, and muscle-specific actin (Figures 3 and 4 ). In some cases the intensity of staining may be helpful in differentiating glomus from glomangiosarcoma. Aiba et al. 13 reported vimentin stained more intensely in the glomangiosarcoma than in the glomus tumor, while the reverse was true for actin and myosin. Furthermore, positive actin staining differentiates glomus cell-derived tumors from hemangiopericytomas, another class of vascular tumors. Malignant variants of hemangiopericytomas may superficially appear similar to the glomus counterpart on routing histologic staining, however, they do not express actin (suggesting a distinct cell of origin). Watanabe et al. 2 recently described a case of a glomangiosarcoma that expressed p53, suggesting a more biologically aggressive tumor. Our case did not stain positive for the p53 marker. Hegyi et al. 10 have also suggested that overexpression of Bcl-2 and inactivation of p53 protein may be involved in the malignant transformation of benign glomus tumors.
The invasive and metastatic potential of glomangiosarcomas remains enigmatic due to the paucity of cases reported. Table 1 summarizes the clinical features of reported malignant glomus tumors. Anagnostou et al. 14 , who reviewed 20 cases of glomus cell tumors, were the first to concisely describe a glomangiosarcoma in a 59year-old man. This tumor, composed of deeply staining nuclei with multiple nucleoli, lacked invasive features and detectable metastases. The malignancy was treated successfully by wide local excision. Enzinger and Weiss 5 described four cases of glomangiosarcoma, two of which invaded surrounding soft tissue. All were excised without recurrence. Gould et al. 12 reported six cases of aggressive, potentially malignant glomus tumors. Although three cases locally recurred, no metastases were observed. Choi et al. 15 reported a very aggressive glomangiosarcoma arising within the mediastinum, with direct extension into the esophagus, trachea, and thyroid glands. In addition, four other cases of metastatic glomangiosarcomas have been described. Kreutz et al. 16 reported a primary lesion from a thigh metastasizing to the maxilla, and Brathwaite and Poppiti 1 reported a case of widespread metastases to the lung, liver, and other organ systems that ultimately proved fatal. Watanabe et al. 4 reported a case of glomangiosarcoma arising from the skin of the left hip which metastasized widely leading to death. Gaertner et al. 11 reported a case of pulmonary glomangiosarcoma that also involved widespread metastases leading to death. Since 1924 there have been fewer than 25 cases of glomangiosarcoma reported. Most cases appear to have arisen from a preexisting glomus tumor without metastasis. Only in five cases have metastases been documented. Four of the five resulted in fatality, and one is presently being treated with radiation and chemotherapy. Clinical, histologic, and immunohistochemical examination are essential in establishing the diagnosis of glomangiosarcoma. Although wide local excision is often successful, we elected to treat our patient with Mohs micrographic surgery to minimize tissue loss. The patient is doing well with no evidence of recurrence or metastasis at 4 years after treatment.
